Ardelyx reported $-27575000 in EBITDA for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Abbott ABT:US $ 3735M 316M
Amgen AMGN:US $ 3341M 185M
Ardelyx ARDX:US $ -27.58M 4.9M
Astrazeneca AZN:US $ 4187M 687M
Biocept BIOC:US $ -2.3M 0.02M
Chimerix CMRX:US $ -24.75M 14.76M
Corcept Therapeutics CORT:US $ 27.06M 9.9M
Curis CRIS:US $ -15.1M 2.57M
Life Technologies LIFE:US $ -12.3M 3.76M
Opko Health OPK:US $ -44.61M 0.72M
Tg Therapeutics TGTX:US $ -66.8M 26.07M
United Therapeutics UTHR:US $ 300.5M 117.1M
Xoma XOMA:US $ -2063000 32.43M